(Q43542743)

24 November 2017

Rebeccamycin analogues from indolo[2,3-c]carbazole (English)

1 reference

24 November 2017

Voldoire A

1

1 reference

24 November 2017

Sancelme M

2

1 reference

24 November 2017

Prudhomme M

3

1 reference

24 November 2017

Colson P

4

1 reference

24 November 2017

Houssier C

5

1 reference

24 November 2017

Bailly C

6

1 reference

24 November 2017

Léonce S

7

1 reference

24 November 2017

Lambel S

8

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Bioorganic & Medicinal Chemistry

24 November 2017

1 reference

24 November 2017

9

1 reference

24 November 2017

357-365

1 reference

24 November 2017

2

1 reference

Staurosporine, a potent inhibitor of phospholipid/Ca++dependent protein kinase

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

K-252a, a potent inhibitor of protein kinase C from microbial origin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Production and biological activity of rebeccamycin, a novel antitumor agent.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

AT2433-A1, AT2433-A2, AT2433-B1, and AT2433-B2 novel antitumor antibiotic compounds produced by Actinomadura melliaura. Taxonomy, fermentation, isolation and biological properties.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

The Camptothecin-Resistant Topoisomerase I Mutant F361S Is Cross-Resistant to Antitumor Rebeccamycin Derivatives. A Model for Topoisomerase I Inhibition by Indolocarbazoles†

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

DNA cleavage by topoisomerase I in the presence of indolocarbazole derivatives of rebeccamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Syntheses and biological activities (topoisomerase inhibition and antitumor and antimicrobial properties) of rebeccamycin analogues bearing modified sugar moieties and substituted on the imide nitrogen with a methyl group.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Calories from carbohydrates: energetic contribution of the carbohydrate moiety of rebeccamycin to DNA binding and the effect of its orientation on topoisomerase I inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Enhanced binding to DNA and topoisomerase I inhibition by an analog of the antitumor antibiotic rebeccamycin containing an amino sugar residue

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Drug-DNA sequence-dependent interactions analysed by electric linear dichroism

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

Electric linear dichroism as a new tool to study sequence preference in drug binding to DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

In vitro cytotoxicity of S16020-2, a new olivacine derivative

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2800%2900251-0

7 January 2021

10.1016/S0968-0896(00)00251-0

Identifiers

DOI

1 reference

24 November 2017

1 reference